Predicting the Concentration of PARP Inhibitors in Human Tumor Tissue Using PBPK Modeling Poster Predicting the Concentration of PARP Inhibitors in Human Tumor Tissue Using PBPK Modeling CertaraSeptember 4, 2019
Performance Verification and Application of a Cancer population for use in Physiologically Based Pharmacokinetic modelling Poster Performance Verification and Application of a Cancer population for use in Physiologically Based Pharmacokinetic modelling CertaraSeptember 4, 2019
Evaluation of maternal drug exposure following the administration of antenatal corticosteroids during late pregnancy using PBPK Modeling Poster Evaluation of maternal drug exposure following the administration of antenatal corticosteroids during late pregnancy using PBPK Modeling CertaraSeptember 4, 2019
INVESTIGATING THE IMPACT OF ENZYME CORRELATIONS ON INTER-INDIVIDUAL VARIABILITY IN PHARMACOKINETICS AND DRUG-DRUG INTERACTIONS Poster INVESTIGATING THE IMPACT OF ENZYME CORRELATIONS ON INTER-INDIVIDUAL VARIABILITY IN PHARMACOKINETICS AND DRUG-DRUG INTERACTIONS CertaraSeptember 4, 2019
Biokinetic and PBPK modelling to support the rotenone and strobilurin read across case studies (CS4) Poster Biokinetic and PBPK modelling to support the rotenone and strobilurin read across case studies (CS4) CertaraSeptember 4, 2019
Biokinetic and PBPK Modelling to Support Read-Across Assessment of Repeat Dose and Developmental and Reproductive Toxicity of Valproic Acid Analogues Poster Biokinetic and PBPK Modelling to Support Read-Across Assessment of Repeat Dose and Developmental and Reproductive Toxicity of Valproic Acid Analogues CertaraSeptember 4, 2019
Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human Poster Physiologically Based Pharmacokinetic/Pharmacodynamic model of gastrointestinal toxicity induced by 5-fluorouracil in mouse and translation to human CertaraSeptember 4, 2019
Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations Poster Use of a Physiologically based Pharmacokinetic – Pharmacodynamic Model to Account for Adjustments to dosing of S-warfarin in Different Populations CertaraSeptember 3, 2019
Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. Poster Quantitative description of the physiological changes in diseased skin and their incorporation into Physiologically Based Pharmacokinetic Models. CertaraSeptember 3, 2019
Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach Poster Predicting Diffusion in the Dermis: a Physiologically Based, Bottom-up Approach CertaraSeptember 3, 2019
